<DOC>
	<DOCNO>NCT00433940</DOCNO>
	<brief_summary>The goal study clarify degree immune suppression infant require therapy create guideline evaluation prevention infection infant oral steroid hemangioma .</brief_summary>
	<brief_title>Immune Suppression Of Infants Treated With Steroids</brief_title>
	<detailed_description>Infants large complicate hemangioma often treat systemically oral steroid . The side effect drug young infant study . The goal study clarify degree immune suppression infant require therapy create guideline evaluation prevention infection infant oral steroid hemangioma . Prednisone start accord establish standard care . Visits occur every four week follow-up . There six blood draw baseline completion study . Approximately 1 Â½ teaspoon per blood sample drawn test strength infant 's immune system . Participation study last 14 month stabilization hemangioma . Evaluation occur 12 week discontinue steroid long-term effect immune system .</detailed_description>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Infants &lt; 6 month age infantile hemangioma require treatment oral corticosteroid Infant must enrol prior initiation steroid therapy Infants &gt; 6 month age Infants already receive oral corticosteroid treatment prior start study Infants know immunodeficiency Infants receive oral medication treatment hemangioma</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Hemangioma</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Prednisone</keyword>
</DOC>